Adverse events associated with intravenous phenytoin in children: A prospective study

Seizure

Volumn 12, Issue 6, 2003, Pages 369-372

  Appleton, Richard E ^a   Gill, Andrea ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Adverse events; Children; Intravenous; Phenytoin; Purple glove syndrome

Indexed keywords

CEREBEYX; FOSPHENYTOIN SODIUM; PHENOBARBITAL; PHENYTOIN; SODIUM CHLORIDE;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EXTRAVASATION; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INFANT; MALE; PERIPHERAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN INFILTRATE; SKIN MANIFESTATION; SKIN NECROSIS; TACHYCARDIA; VEIN OCCLUSION;

EID: 0041353787     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(02)00338-2     Document Type: Article

References (16)

1. Mattson, R. H. Parenteral antiepileptic/anticonvulsant drugs. Neurology 1996; 46 (Suppl. 1): S8-S13.
2. Earnest, M. P., Marx, J. A. and Drury, L. R. Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. Journal of the American Medical Association 1983; 249: 762-765.
3. Kilarski, D. J., Buchanan, C. and Von Behren, L. Soft-tissue damage associated with intravenous phenytoin. New England Journal of Medicine 1984; 311: 1186-1187.
4. Spengler, R. F., Arrowsmith, J. B., Kilarski, D. J., Buchanan, C., Von Behren, L. and Graham, D. R. Severe soft-tissue injury following intravenous infusion of phenytoin. Archives of Internal Medicine 1988; 148: 1329-1333.
5. Hayes, A. G. and Chesney, T. M. Necrosis of the hand after extravasation of intravenously administered phenytoin. Journal of the American Academy of Dermatology 1993; 28: 360-363.
6. O'Brien, T. J., Cascino, G. D., So, E. L. and Hanna, D. R. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998; 51: 1034-1039.
7. Burneo, J. G., Anandan, J. V. and Barkley, G. L. A prospective study of the incidence of the purple glove syndrome. Neurology 2001; 42: 1156-1159.
8. Browne, T. R. Intravenous phenytoin: cheap but not necessarily a bargain. Neurology 1998; 51: 942-943.
9. Collins, M., Gidal, B. E., Garnett, W. R., Reinfeldt, G. and Tusch, G. M. Potential under-reporting of intravenous phenytoin adverse events. Annals of Pharmacotherapy 1999; 33: 111-112.
10. Browne, T. R., Kugler, A. R. and Eldon, M. A. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996; 46 (Suppl. 1): S3-S7.
11. Browne, T. R. Fosphenytoin (Cerebyx). Clinical Neuropharmacology 1997; 20: 1-12.
12. Morton, L. D. Clinical experience with fosphenytoin in children. Journal of Child Neurology 1998; 13 (Suppl. 1): S19-S22.
13. Wilder, B. J. Use of parenteral antiepileptic drugs and the role for fosphenytoin. Neurology 1996; 46 (Suppl. 1): S1-S2.
14. CSM. Fosphenytoin sodium: serious arrhythmias and hypotension. Current Problems in Pharmacovigilance 2000; 26: 1.
15. Marchetti, A., Magar, R., Fischer, J., Sloan, E. and Fischer, P. A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx®) versus intravenous phenytoin (Dilantin®) in hospital emergency departments. Clinical Therapeutics 1996; 18: 953-966.
16. Graves, D. Pharmacoeconomic considerations in treatment options for acute seizures. Journal of Child Neurology 1998; 13 (Suppl. 1): S27-S29.